UBC leads national study on HPV vaccine

Clinician-scientists in the Faculty of Medicine are leading a new study that seeks to determine whether two or three doses of the vaccine Gardasil provide similar protection against human papillomavirus (HPV). The study is designed to assess risk for HPV disease, HPV prevalence, and the levels of protection provided by two doses compared to three doses of the vaccine.

The study’s co-principal investigators are Gina Ogilvie, associate professor of Family Practice and medical director of Clinical Prevention Services at the B.C. Centre for Disease Control (BCCDC), and professor of Pathology and Laboratory Medicine Mel Krajden, the medical director of Hepatitis Services at BCCDC.

To participate in the study, visit www.questhpvstudy.ca or call 604-875-2000 ext. 6501, or toll free 1-866-502-2424. For more information, click here.